Bariatric surgery helps T2DM patients by reducing hepatic steatosis
In a new research, Kathrine Aglen Seeberg and colleagues have found that Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) were both extremely successful in decreasing hepatic steatosis, with an almost full clearance of liver fat 1 year after surgery. In the near term, bariatric surgery had less of an effect on the degree of fibrosis, but long-term progression must be...
In a new research, Kathrine Aglen Seeberg and colleagues have found that Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) were both extremely successful in decreasing hepatic steatosis, with an almost full clearance of liver fat 1 year after surgery. In the near term, bariatric surgery had less of an effect on the degree of fibrosis, but long-term progression must be assessed.
Losing weight helps with fatty liver disease. There has been no randomized investigation comparing the effects of SG and RYGB on liver fat content and fibrosis. Therefore, this study aims to compare the effects of SG and RYGB on hepatic steatosis and fibrosis over a one-year period.
For more information check out the below:
Bariatric Surgery Helps Reduce Hepatic Steatosis In Type 2 Diabetes Patients
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd